Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree. Paxlovid, which consists of two different antiviral drugs—nirmatrelvir and ritonavir—is currently approved or authorized for conditional or…
Pfizer Stops Enrollment in COVID-19 Pill Trial After Drug Performs Poorly
Pfizer Stops Enrollment in COVID-19 Pill Trial After Latest Results
Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree. Paxlovid, which consists of two different antiviral drugs—nirmatrelvir and ritonavir—is currently approved or authorized for conditional or…
Pfizer to Invest $120 Million in COVID-19 Pill as Officials Issue Alert
Pfizer announced Monday that it would spend $120 million to expand U.S. manufacturing of its oral COVID-19 antiviral pill at its Michigan facility. Use of Pfizer’s Paxlovid pill in treatment of newly infected cases has risen even as the U.S. Centers for Disease Control and Prevention (CDC) warned the pill can lead to a rebound…
Facts Matter (June 2): CDC Issues Warning on Pfizer’s Covid Pills, Alerts Issued For “Covid Rebound” and Positive Viral PCR Tests
The CDC recently issued a warning regarding Pfizer’s COVID-19 pills—the ones that were approved last year and sold under the name Paxlovid. People usually take those pills after they contract COVID-19 to lessen the symptoms and lower the chance of hospitalization. However, a new advisory from the CDC warns Americans that taking Paxlovid can actually…
Pfizer COVID-19 Pill Does Not Provide Significant Benefit in Patients Under 65: Study
June 2, 2022
admin
BrightCCP VirusCovid NewshealthHealth NewsMiddle EastPaxlovidPfizerPUBLIC HEALTH INFORMATIONUSUS NewsWorld
0 Comment
Pfizer’s COVID-19 pill helps reduce COVID-19 hospitalizations and deaths in the elderly but provides no strong benefit for those under 65, according to a new study. Researchers in Israel gleaned data from Clalit Health Services, a health care organization that covers over half of the entire population in the country. They analyzed data from the…
All About the Newest COVID Pills – Should You Take Them?
Pfizer’s new antiviral pill Paxlovid is receiving high-profile attention – the vice president even took it when she contracted COVID. But a strange phenomenon is being reported by some of its users, raising the question if it, too, should be avoided. Story at-a-glance So far, all of the drugs developed against COVID-19 have been disastrous…
FDA Investigating Reports of COVID Relapses Following Use of Pfizer’s Pill
May 4, 2022
admin
AMERICABrightCCP VirusCovid NewsEditor's PickshealthHealth NewsPaxlovidPfizerPUBLIC HEALTH INFORMATIONUSUS News
0 Comment
The U.S. Food and Drug Administration (FDA) is investigating reports of relapses among people who took Pfizer’s COVID-19 pill. The FDA “is evaluating the reports of viral load rebound after completing paxlovid treatment and will share recommendations if appropriate,” an agency spokesperson told The Epoch Times in an email. In a recent preprint case report,…
Pfizer Says Its COVID-19 Pill Paxlovid Fails to Prevent Symptomatic Infection of Household Members
Pfizer announced Friday that a recent large, late-stage trial found that its COVID-19 antiviral pill, Paxlovid, failed at preventing symptomatic infection of people living with a person who has the disease. The trial enrolled 2,957 participants aged 18 and older who live in the same household as another person who has COVID-19 with symptoms. They were given either…
[PREMIERING NOW] PART 2: Dr. Richard Urso: Big Pharma Makes Billions by Rebranding Existing Drugs as ‘New’ Products
April 23, 2022
admin
American Thought LeadersCCP VirusCOVID-19dr. richard ursoEpochTVExpert ViewInternational Alliance of Physicians and Medical ScientistsLive VideosPaxlovidPublic HealthUSVideo
0 Comment
This episode will premiere on Saturday, April 23, at 6 p.m. ET! “We have seen the ultimate demise of our health care system when it’s in the hands of bureaucrats,” says Dr. Richard Urso, a co-founder of the International Alliance of Physicians and Medical Scientists. Previously, in part one of our interview, we…
PART 2: Dr. Richard Urso: Big Pharma Makes Billions by Rebranding Existing Drugs as ‘New’ Products
April 23, 2022
admin
American Thought LeadersCCP VirusCOVID-19dr. richard ursoEpochTVExpert ViewInternational Alliance of Physicians and Medical ScientistsLive VideosPaxlovidPublic HealthUSVideo
0 Comment
“We have seen the ultimate demise of our health care system when it’s in the hands of bureaucrats,” says Dr. Richard Urso, a co-founder of the International Alliance of Physicians and Medical Scientists. Previously, in part one of our interview, we discussed alarming post-booster trends he’s seen and how usual protocols for identifying treatments were…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`